[April 15, 2013] Agere Pharmaceuticals Enhances Drug Delivery Platform Tweet Apr 15, 2013 (Close-Up Media via COMTEX) -- Agere Pharmaceuticals, Inc., an oral bioavailability contract research and manufacturing organization, announced that it has enhanced the Agere drug delivery platform to include prediction technology that identifies best-fit polymer candidates for drug solubilization and formulation. According to a release, Agere's polymer-selection system for drugs integrates directed experiments with rigorous computations to predict and measure key functions of the drug and candidate polymers. These functions are analyzed to accurately predict and rank order empirically-observed behaviors of the drug-polymer compound. "Our new technology further extends the Agere platform to leverage formulation design automation and analysis using fundamental science and proprietary techniques," said Marshall Crew, president and CEO of Agere. "Our goal was to put a system in place that enables us to quickly consider an expanding spectrum of likely excipients in order to achieve the best bioavailability options for our clients." Agere services span formulation design and development into clinical trial drug manufacturing. All services are offered "`a la carte", allowing companies the flexibility to engage with Agere at any stage in their process. Agere provides all services on a fee-for-service basis, in which Agere assumes no intellectual property ownership over work done on behalf of the company's clients. ((Comments on this story may be sent to [email protected])) [ Back To TMCnet.com's Homepage ]